TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023)
TherapeuticsMD (TXMD) reported Other Non Operating Income of $359000.0 for Q3 2023, up 420.54% on a YoY basis from $68967.4 in Q3 2022, and up 248.54% quarter-over-quarter from $103000.0 in Q2 2023.
TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023) Analysis & Trends
TherapeuticsMD has reported Other Non Operating Income for 12 years, with the latest figure at $359000.0 in Q3 2023.
- For the quarter ending Q3 2023, Other Non Operating Income rose 420.54% year-over-year to $359000.0; the trailing twelve-month figure through Sep 2023 stood at $880000.0 (up 110.33% YoY), and the FY2022 full-year result was -$117000.0, down 143.01% from the prior year.
- Other Non Operating Income for Q3 2023 stood at $359000.0, up from $103000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $12.6 million in Q4 2019, with the low at -$10.1 million in Q2 2019.
- Historically, Other Non Operating Income has averaged -$154104.5 across 5 years, with a median of $103000.0 in 2023.
- Annual changes were most pronounced in 2019 — Other Non Operating Income soared 1425.79% — and 2022, when it slumped 6985.25%.
- TherapeuticsMD's Other Non Operating Income stood at $12.6 million in 2019, then slumped by 98.95% to $132000.0 in 2020, then plunged by 93.94% to $8000.0 in 2021, then jumped by 37.5% to $11000.0 in 2022, then surged by 3163.64% to $359000.0 in 2023.
- The last three Other Non Operating Income figures came in at $359000.0 (Q3 2023), $103000.0 (Q2 2023), and $407000.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | TherapeuticsMD | 25,462.80 | -8.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 359,000.00 |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | 407,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -8.40 Mn |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 123,000.00 |
| Mar 31, 2021 | 122,000.00 |
| Dec 31, 2020 | 132,000.00 |
| Sep 30, 2020 | 42,000.00 |
| Jun 30, 2020 | 89,000.00 |
| Mar 31, 2020 | 335,000.00 |
| Dec 31, 2019 | 12.56 Mn |
| Sep 30, 2019 | 703,662.00 |
| Jun 30, 2019 | -10.10 Mn |
| Mar 31, 2019 | 688,721.00 |
| Dec 31, 2018 | 823,027.00 |